This inventor holds 2 USPTO granted patents and 12 published patent applications and 1 EPO patent. Top assignee: Kymab Limited. Active years: 2019-2023.
Company Filing History:
Years Active: 2019-2023
Title: Anais Legent: Innovator in Therapeutic Antibodies
Introduction
Anais Legent is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of therapeutic antibodies, holding a total of 2 patents. Her work focuses on innovative methods for generating chimaeric antibodies and their applications in medical treatments.
Latest Patents
Anais Legent's latest patents include groundbreaking inventions. The first patent, titled "Animal models and therapeutic molecules," discloses methods for generating chimaeric human—non-human antibodies and chimaeric antibody chains. This invention also covers the production of fully humanized antibodies, along with compositions that include these antibodies, antibody chains, and derivatives. The second patent, "Anti-LIGHT antibodies," relates to anti-human LIGHT antibodies and explores new medical uses and methods for these antibodies.
Career Highlights
Anais Legent is currently associated with Kymab Limited, where she continues to advance her research in therapeutic antibodies. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the development of novel treatments.
Collaborations
Anais collaborates with notable colleagues, including Ian Kirby and Jamie Iain Campbell. Their combined expertise enhances the research and development efforts at Kymab Limited.
Conclusion
Anais Legent is a trailblazer in the field of therapeutic antibodies, with her patents paving the way for new medical advancements. Her contributions are vital to the ongoing evolution of biotechnology and therapeutic solutions.